The Earth Times Online Newspaper (Free subscription) | 08/04/2008
ALISO VIEJO, Calif. - Valeant Pharmaceuticals International (NYSE:VRX) announced today that it had agreed to sell its business operations located in Western Europe, Eastern Europe including Russia, and certain export markets to Meda AB, an international specialty pharmaceutical company locat
Business Wire (Free subscription) | 08/04/2008
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE:VRX) announced today that it had agreed to sell its business operations located in Western Europe, Eastern
Business Wire (Free subscription) | 07/21/2008
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will host a conference call on Monday, August 11, 2008 at 11:00 a.m. EDT (8:00
Business Wire (Free subscription) | 06/20/2008
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will redeem all of the $300 million aggregate principal amount outstanding of
The Earth Times Online Newspaper (Free subscription) | 06/17/2008
ALISO VIEJO, Calif. - Valeant Pharmaceuticals International (NYSE: VRX) today announced that its board of directors has authorized the repurchase of an additional $100 million of its outstanding common stock under its 2007 stock repurchase program. This repurchase authorization raises the ag
Business Wire (Free subscription) | 06/17/2008
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE: VRX) today announced that its board of directors has authorized the repurchase of an additional $100
Market Watch (Free subscription) | 06/10/2008
NEW YORK (MarketWatch) -- Valeant Pharmaceuticals International said Tuesday it has divested its commercial operations in Argentina to an unnamed Argentinean pharmaceutical company. Financial terms were not disclosed. "One of our strategic initiatives for 2008 is to divest certain regions and simplify our operations," Chairman and CEO Michael Pearson said in the statement announcing the move. Market...
Business Wire (Free subscription) | 06/10/2008
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE:VRX) announced today that it has divested its Argentina commercial operations to one of the leading
GuruFocus Updates (Free subscription) | 06/07/2008
Highlight of weekly top CEO buys. Related Companies: General Electric Company (GE), Dick's Sporting Goods Inc. (DKS), Inverness Medical Innovations Inc (IMA), Valeant Pharmaceuticals International (VRX), Huntsman Corp. (HUN).
Business Wire (Free subscription) | 06/04/2008
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE: VRX) today announced members of its senior management team will make a presentation at the Goldman Sachs
Business Wire (Free subscription) | 05/19/2008
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE:VRX) today announced that it will conduct a live webcast of the company's
Business Wire (Free subscription) | 05/15/2008
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals (NYSE:VRX) today announced that the Food and Drug Administration (the FDA) has entered an administrative order
Seeking Alpha (Free subscription) | 05/14/2008
Valeant Pharmaceuticals International (VRX) Q1 2008 Earnings Call Complete Story ยป
Red Orbit (Free subscription) | 05/13/2008
Valeant Pharmaceuticals International (NYSE:VRX) today reported positive results for retigabine in RESTORE 2, the second of two Phase III pivotal trials, for this first-in-class neuronal potassium channel opener.
Business Wire (Free subscription) | 05/07/2008
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE:VRX) today announced first quarter financial results for 2008. Revenues:
